I will put a guess out there that the April compounding pharmacy revenue will easily top the $494K from last month. Without mentioning the other revenue streams, it is exciting to know this .10 cent penny stock will be cash flow positive in the very near future. Notes are being absorbed and revenues are being generated. Get excited CORE. GO SCRC!!!
